BBlogFlow

Study calls for public health action on kids' screen time - CBC

·Oct 4, 2026

This story deserves to be shared

Send it to someone who'd care, or post it on your networks.

Facebook Twitter Email

Skip to Main ContentAccessibility HelpMenuCBC GemCBC ListenSearchQuick LinksNewsSportsRadioMusicListen LiveTVWatchnewsTop StoriesLocalClimateWorldCanadaPoliticsIndigenousBusinessThe NationalHealthEntertainmentScienceCBC News InvestigatesDisability LifeGo PublicAbout CBC NewsBeing Black in CanadaVideoStudy calls for public health action on kids' screen time | CBC.ca LoadedStudy calls for public health action on kids' screen timeOctober 4|Duration 2:01October 4NewsDuration 2:01closed captionExcessive screen time is taking a toll on young people's health, according to a major new study. Researchers warn it's linked to anxiety, depression and poor sleep. They're urging governments to intervene. Related StoriesKids and young adults are addicted to screens. New research argues it may be a public health concernThe mental health of young men is declining. Experts warn it could get worseQ&A: This doctor says he's seeing the harms of social media on youthYoung people want to know if they're neurodivergent. Here's what doctors say is going onShould kids living with obesity be on GLP-1s?

This article is an excerpt. To read the full content, visit the original source. CBC

Reactions

0 comments

No comments yet. Be the first to share your thoughts!

Facebook Twitter

Related articles

Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress

Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.

Medical Xpress·

Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily

“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.

Oncodaily·